172 related articles for article (PubMed ID: 17204136)
1. Protocol for the THREAD (THREshold for AntiDepressants) study: a randomised controlled trial to determine the clinical and cost-effectiveness of antidepressants plus supportive care, versus supportive care alone, for mild to moderate depression in UK general practice.
Chatwin J; Kendrick T;
BMC Fam Pract; 2007 Jan; 8():2. PubMed ID: 17204136
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
[TBL] [Abstract][Full Text] [Related]
3. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
5. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial.
Sharp DJ; Chew-Graham C; Tylee A; Lewis G; Howard L; Anderson I; Abel K; Turner KM; Hollinghurst SP; Tallon D; McCarthy A; Peters TJ
Health Technol Assess; 2010 Sep; 14(43):iii-iv, ix-xi, 1-153. PubMed ID: 20860888
[TBL] [Abstract][Full Text] [Related]
6. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
Edwards SJ; Hamilton V; Nherera L; Trevor N
Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
[TBL] [Abstract][Full Text] [Related]
10. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
12. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
[TBL] [Abstract][Full Text] [Related]
13. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
Tallon D; Wiles N; Campbell J; Chew-Graham C; Dickens C; Macleod U; Peters TJ; Lewis G; Anderson IM; Gilbody S; Hollingworth W; Davies S; Kessler D
Trials; 2016 Feb; 17():66. PubMed ID: 26842107
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant treatment for postnatal depression.
Brown JVE; Wilson CA; Ayre K; Robertson L; South E; Molyneaux E; Trevillion K; Howard LM; Khalifeh H
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013560. PubMed ID: 33580709
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
18. Using non-steroidal anti-inflammatory drugs in the treatment of depression.
Davis A; Gilhooley M; Agius M
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S49-52. PubMed ID: 21057403
[TBL] [Abstract][Full Text] [Related]
19. Psychological therapies for treatment-resistant depression in adults.
Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
